戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1366021作成日:2026年10月23日

Triethylamine → N-[(3R)-6-(4-Hydroxyphenyl)-2-oxoazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide

https://huagongshe.com/ja/reaction/1366021

反応式

関与物質

役割名称HCID仕込み量
反応物TriethylamineHCID 8471—
反応物DiisopropylethylamineHCID 81531—
反応物4-Nitrophenyl chloroformateHCID 82129—
反応物1-(piperidin-4-yl)-1H,2H,3H-imidazo[4,5-b]pyridin-2-one dihydrochlorideHCID 22293181—
反応物(3R)-3-Amino-6-(4-hydroxyphenyl)azepan-2-oneHCID 60037861—
溶媒DimethylformamideHCID 6228—
溶媒TetrahydrofuranHCID 8028—
生成物N-[(3R)-6-(4-Hydroxyphenyl)-2-oxoazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamideHCID 2365658733.5%

反応手順

Triethylamine (0.009 mL, 0.091 mmol) was added to a solution of (3R)-3-amino-6-(4-hydroxyphenyl)azepan-2-one (10 mg, 0.045 mmol) and 4-nitrophenyl chloroformate (18 mg, 0.091 mmol) in N,N-dimethylformamide (0.2 mL) and tetrahydrofuran (0.2 mL) at 0° C. After 1 h, 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride (26 mg, 0.091 mmol) and diisopropylethylamine (0.032 mL, 0.182 mmol) were added and the mixture was allowed to warm to ambient temperature. After 18 h, the mixture was purified by reverse phase HPLC (C-18, 95% water/acetonitrile→5% water/acetonitrile with 0.1% trifluoroacetic acid) to give the title compound (7 mg). MS 465.2243 (M+1).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07893052B2
出典データセットuspto-grants-2011_02
ORD IDord-621e893a35514415a8c589a41f9e90ae
出典メモuspto-grants-2011_02